Expansion of natural killer cell receptor (CD94/NKG2A)-expressing cytolytic CD8 T cells and CD4+CD25+ regulatory T cells from the same cord blood unit

Experimental Hematology

Volumn 35, Issue 10, 2007, Pages 1562-1566

  Tanaka, Junji ^a   Sugita, Junichi ^a   Kato, Naoko ^a   Toubai, Tomomi ^a   Ibata, Makoto ^a   Shono, Yusuke ^a   Ota, Shuichi ^a   Kondo, Takeshi ^a   Kobayashi, Takahiko ^a   Kobayashi, Masanobu ^a   Asaka, Masahiro ^a   Imamura, Masahiro ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIBODY; CD4 ANTIGEN; CD8 ANTIGEN; CD94 ANTIGEN; CHROMIUM 51; INTERLEUKIN 2 RECEPTOR ALPHA; MESSENGER RNA; MONOCLONAL ANTIBODY CD28; NATURAL KILLER CELL RECEPTOR NKG2A; TRANSCRIPTION FACTOR FOXP3;

ANTIGEN EXPRESSION; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL FRACTIONATION; CELL ISOLATION; CHROMIUM 51 RELEASE; COCULTURE; CONTROLLED STUDY; CYTOLYSIS; EFFECTOR CELL; GRAFT VERSUS LEUKEMIA EFFECT; HUMAN; HUMAN CELL; MIXED LEUKOCYTE CULTURE; NATURAL KILLER T CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; UMBILICAL CORD BLOOD;

ANTIGENS, CD94; CD8-POSITIVE T-LYMPHOCYTES; CELL CULTURE TECHNIQUES; CELLS, CULTURED; CORD BLOOD STEM CELL TRANSPLANTATION; FETAL BLOOD; GENE EXPRESSION REGULATION; GRAFT VS HOST DISEASE; GRAFT VS LEUKEMIA EFFECT; HUMANS; K562 CELLS; LYMPHOCYTE DEPLETION; RECEPTORS, IMMUNOLOGIC; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION, HOMOLOGOUS;

EID: 34548690331     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2007.06.006     Document Type: Article

References (28)

1. Ljunggren H.G., and Karre K. In search of the "missing self". MHC molecules and NK cell recognition. Immunol Today 11 (1990) 237-244
2. Moretta A., Biassoni R., Bottino C., et al. Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes. Immunol Rev 155 (1997) 105-117
3. Bakker A.B.H., Phillips J.H., Figdor C.G., and Lanier L.L. Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, γδ T cells, and antigen-specific CTL. J Immunol 160 (1998) 5239-5245
4. Phillips J.H., Gumperz J.E., Parham P., and Lanier L.L. Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes. Science 268 (1995) 403-405
5. + T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. Proc Natl Acad Sci U S A 93 (1996) 12433-12438
6. + T cells is controlled by T-cell receptor engagement. Nature 403 (2000) 325-328
7. Braud V.M., Allan D.S.J., O'Callaghan C.A., et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 391 (1998) 795-799
8. Ulbrecht M., Honka T., Person S., Johnson J.P., and Weiss E.H. The HLA-E gene encodes two differentially regulated transcripts and a cell surface protein. J Immunol 149 (1992) 2945-2953
9. Borrego F., Ulbrech M., Weiss E.H., Coligan J.E., and Brooks A.G. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLAS class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J Exp Med 187 (1998) 813-818
10. Derre L., Corvaisier M., Pandolfino M.C., Diez E., Jotereau F., and Gervois N. Expression of CD94/NKG2-A on human T lymphocytes is induced by IL-12: implications for adoptive immunotherapy. J Immunol 168 (2002) 4864-4870
11. Tanaka J., Toubai T., Tsutsumi Y., et al. Cytolytic activity and regulatory functions of inhibitory NK cell receptor-expressing T cells expanded from granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells. Blood 104 (2004) 768-774
12. Tanaka J., Iwao N., Toubai T., et al. Cytolytic activity against primary leukemic cells by inhibitory NK cell receptor (CD94/NKG2A)-expressing T cells expanded from various sources of blood mononuclear cells. Leukemia 19 (2005) 486-489
13. Nguyen V.H., Zeiser R., and Negrin R.S. Role of naturally arising regulatory T cells in hematopoietic cell transplantation. Biol Blood Marrow Transplant 12 (2006) 995-1009
14. Rezvani K., Mielke S., Ahmadzadeh M., et al. High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT. Blood 108 (2006) 1291-1297
15. Xia G., He J., Zhang Z., and Leventhal J.R. Targeting acute allograft rejection by immunotherapy with ex vivo-expanded natural CD4+ CD25+ regulatory T cells. Transplantation 82 (2006) 1749-1755
16. Godfrey W.R., Ge Y.G., Spoden D.J., et al. In vitro-expanded human CD4(+)CD25(+) T-regulatory cells can markedly inhibit allogeneic dendritic cell-stimulated MLR cultures. Blood 104 (2004) 453-461
17. Zheng S.G., Wang J.H., Gray J.D., Soucier H., and Horwitz D.A. Natural and induced CD4+CD25+ cells educate CD4+CD25- cells to develop suppressive activity: the role of IL-2, TGF-beta, and IL-10. J Immunol 172 (2004) 5213-5221
18. Godfrey W.R., Spoden D.J., Ge Y.G., et al. Cord blood CD4(+)CD25(+)-derived T regulatory cell lines express FoxP3 protein and manifest potent suppressor function. Blood 105 (2005) 750-758
19. Li L., Godfrey W.R., Porter S.B., et al. CD4+CD25+ regulatory T-cell lines from human cord blood have functional and molecular properties of T-cell anergy. Blood 106 (2005) 3068-3073
20. Zheng S.G., Wang J.H., Gray J.D., Soucier H., and Horwitz D.A. Natural and induced CD4+CD25+ cells educate CD4+CD25- cells to develop suppressive activity: the role of IL-2, TGF-beta, and IL-10. J Immunol 172 (2004) 5213-5221
21. Carson W.E., Giri J.G., Lindemann M.J., et al. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med 180 (1994) 1395-1403
22. Rutella S., Pierelli L., Bonanno G., et al. Immune reconstitution after autologous peripheral blood progenitor cell transplantation: effect of interleukin-15 on T-cell survival and effector functions. Exp Hematol 29 (2001) 1503-1516
23. Lin S.J., Cheng P.J., Yan D.C., Lee P.T., and Hsaio H.S. Effect of interleukin-15 on alloreactivity in umbilical cord blood. Transpl Immunol 16 (2006) 112-116
24. Ghiringhelli F., Menard C., Martin F., and Zitvogel L. The role of regulatory T cells in the control of natural killer cells: relevance during tumor progression. Immunol Rev 214 (2006) 229-238
25. Smyth M.J., Teng M.W., Swann J., Kyparissoudis K., Godfrey D.I., and Hayakawa Y. CD4+CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer. J Immunol 176 (2006) 1582-1587
26. Lin C.Y., Graca L., Cobbold S.P., and Waldmann H. Dominant transplantation tolerance impairs CD8+ T cell function but not expansion. Nat Immunol 12 (2002) 1208-1213
27. Mempel T.R., Pittet M.J., Khazaie K., et al. Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation. Immunity 25 (2006) 129-141
28. Miyara M., and Sakaguchi S. Natural regulatory T cells:mechanisms of suppression. Trends Mol Med 13 (2007) 108-116